report: afederation.substack.com/p/regulome-r...
tech access application:https://forms.gle/bCi22VnZqbBD3qQq5
@afederation.bsky.social
Co-founder, CEO of Talus Bio. Drugging "undruggable" transcription factors with proteomics #chembio. Scientist, mountain runner, new dad. https://readout.substack.com
report: afederation.substack.com/p/regulome-r...
tech access application:https://forms.gle/bCi22VnZqbBD3qQq5
Now we can finally read it. Full write-up in the comments.
More experiments coming:
- Sleep deprivation (new baby incoming)
- Ultramarathon recovery
- Sauna // ice bath
- Alcohol
What else do you want to see? Follow along. Subscribe for updates. Apply for access to our tech.
The answer lives in the regulome. It's your bodyβs real-time operating system, interpreting the environment and making decisions
It decides how your genome responds to stress, sleep, food, toxins, exercise, and more.
Well, why do you sometimes wake up feeling like garbage after eight hours of sleep? Your HRV looks fine. You got your morning sunlight. Your bloodwork is normal. Even your genome doesn't have a glaring mutation.
10.07.2025 12:14 β π 0 π 0 π¬ 1 π 0I just ran the first n=1 dynamic regulome experiment. On myself.
A 72-hour fast where we tracked all 4,000+ components of the genome regulatory 'software' to see how they respond
And over 30% changed, most never mentioned in fasting literature
Why does this matter?
Audience in lecture hall
Pavel Sinitcyn presenting
Katerina Nastou presenting
Will Fondrie presenting
The EUBIC-MS Developers Meeting 2025 in Brixen is off to a great start with keynotes by Pavel Sinitcyn, Katerina Nastou, and @willfondrie.com.
#EuBIC2025
Itβs been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). Iβm reaching out to identify clinicians/patients who have encountered pediatric IDCS or other (non-LCH) dendritic or histiocytic sarcomas cases.
08.02.2025 21:21 β π 1011 π 850 π¬ 83 π 32Some diseases are too rare to be VC-fundable. Without grant funding, these patients get nothingβthatβs unacceptable.
NIH grants fund our work on a rare cancer with no approved treatments. Every year, we pay out of pocket for a third-party audit to prove thereβs no waste, no fraudβjust science.
Does anyone know if the savings will be re-invested into more grants?
Or is this just slashing the overall budget of the NIH?
Love to see more teams getting into the multidimensional drug screening game with DIA proteomics.
380 kinases in one assay -
pubs.acs.org/doi/10.1021/...
Getting a bit tight in the hallways #teamMassSpec #proteomics
27.01.2025 21:56 β π 58 π 2 π¬ 2 π 0That seems... like a reasonable number? I'm surprised it's not higher, especially since a postdoc will usually double their salary going into industry
www.nature.com/articles/d41...
Cancer might be the most creative biologist - it's evolutionary "job" is to stress test every biological mechanism in our cells are see if promoted survival/fitness
Apparently tumors can tunnel into lymphocytes and dump their mutated mitochondria?
What a wild world
This is the perspective I was waiting for after seeing all the new transcription factor footprinting papers π
25.01.2025 23:18 β π 1 π 0 π¬ 0 π 0Nice discussion here - we're doing our part building the first proteomics search engine that can handle the scale needed for drug discovery
www.nautilus.bio/blog/transla...
US Scientists already on it - Phase I announcement
www.globenewswire.com/news-release...
@willfondrie.com cool pre-print extended to more interesting chemical space
22.01.2025 01:53 β π 2 π 0 π¬ 0 π 0I'm not sure how I missed this, but apparently there's a flash of light when the egg gets fertilized!?
Pretty wild
www.nature.com/articles/sre...
Re-upping this reply thread from last night. Drugs don't come from nowhere, folks. And we're not ripping off the NIH, either.
06.01.2025 14:36 β π 78 π 23 π¬ 5 π 1
This update of may also help Bristol-Myers Squibb keep Opdivo on the market longer, as the original drug's patent is likely to be expiring soon.
This means treatment is much faster, only 3-5 minutes instead of 30 minutes. This could be more comfortable for patients and eventually allow self-administration at home.
05.01.2025 16:14 β π 0 π 0 π¬ 1 π 0Opdivo Qvantig is a new subcutaneous version of the cancer drug Opdivo.
It works the same way as Opdivo, blocking the PD-1 receptor on T cells to help the immune system fight cancer. But, it's given as a shot under the skin instead of an infusion into a vein.
New Drug Approval: Opdivo Qvantig from BMS
www.drugs.com/newdrugs/fda...
Lots of really cool molecules here. The menin inhibitors are super important. No new transcription factor inhibitors, sadly. On to 2025 π
03.01.2025 14:54 β π 5 π 1 π¬ 0 π 0First @chorylab.bsky.social blog post!
chorylab.substack.com/p/new-year-n...
Y'all better watch out, there's more (data) where that came from!
31.12.2024 05:40 β π 1 π 0 π¬ 1 π 0Don't think I've ever read something this moving about gene regulation before
28.12.2024 20:00 β π 2 π 0 π¬ 0 π 0Wow. Very impressive work with in vivo dTAG looking at KRAS G12V.
Lots more to learn with this technology, this is only the start. Congratulations Behnam and team!
People sometimes make fun of science that sounds stupid and random.
Meanwhile, a study of lizard saliva turned into a peptide medication, which was turned into a diabetes medication, which was turned into a GLP1 weight loss drug, that just became the first therapy every approved for β¦ sleep apnea
Spatial proteomics wins method of the year!
Our team at @talusbio.bsky.social isn't using IF-based spatial proteomics, TF-Scan does provide a surrogate of protein localization within the nucleus, with enough throughput to be useful for drug discovery.
www.nature.com/articles/s41...